| 101 |
20798257 | Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. | 2010 Sep |
4 |
| 102 |
20960258 | Mutation analysis and serum FGF23 level in a patient with pulmonary alveolar microlithiasis. | 2010 Apr |
1 |
| 103 |
19121771 | Klotho gene, phosphocalcic metabolism, and survival in dialysis. | 2009 Jan |
2 |
| 104 |
19190675 | Latest findings in phosphate homeostasis. | 2009 May |
2 |
| 105 |
19382073 | [Phosphatonins: novel insights and clinical perspectives]. | 2009 Mar-Apr |
1 |
| 106 |
19462937 | Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients. | 2009 |
1 |
| 107 |
19464978 | [A new axis of phosphate balance control: fibroblast growth factor 23-Klotho]. | 2009 Nov |
1 |
| 108 |
19480830 | [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control]. | 2009 May |
2 |
| 109 |
19770756 | Fibroblast growth factor 23 and the future of phosphorus management. | 2009 Nov |
1 |
| 110 |
19797911 | Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease? | 2009 |
4 |
| 111 |
19838340 | Evaluation of the role of FGF23 in mineral metabolism. | 2009 Aug 3 |
4 |
| 112 |
20107581 | FGF-23 Levels before and after Renal Transplantation. | 2009 |
1 |
| 113 |
18230836 | Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. | 2008 Feb |
2 |
| 114 |
18256372 | Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. | 2008 May |
2 |
| 115 |
18660671 | Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. | 2008 Jul |
1 |
| 116 |
17293108 | 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. | 2007 Mar |
1 |
| 117 |
17359508 | Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. | 2007 May |
3 |
| 118 |
17565275 | Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. | 2007 Jul |
2 |
| 119 |
17635819 | Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. | 2007 Jul-Aug |
2 |
| 120 |
17982392 | Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. | 2007 Aug |
1 |
| 121 |
16941023 | Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? | 2006 Oct |
4 |
| 122 |
15613425 | Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. | 2005 Mar |
2 |
| 123 |
15698453 | Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. | 2005 Mar |
4 |
| 124 |
15917335 | Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. | 2005 Jul |
3 |
| 125 |
15956805 | Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism. | 2005 |
4 |
| 126 |
16076376 | Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism. | 2005 Aug |
1 |
| 127 |
16234967 | Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D. | 2005 Nov |
2 |
| 128 |
16292192 | [FGF23, a "new" hormone regulating phosphate homeostasis and vitamin D metabolism]. | 2005 Nov 5 |
1 |
| 129 |
17373206 | [What are the actual indications for a surgical parathiroidectomy?]. | 2005 Dec |
2 |
| 130 |
15264182 | Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. | 2004 Aug |
2 |
| 131 |
12419819 | Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. | 2003 Jan 24 |
1 |
| 132 |
14633152 | Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. | 2003 Dec |
1 |